Founders Capital Management, LLC Merck & Co., Inc. Transaction History

Founders Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 27, 2022	SELL	$72.28 - $90.54 $5.1 Million - $6.39 Million	-70,606 Closed	0 $0
Q3 2021 Oct 21, 2021	SELL	$71.68 - $78.83 $137,768 - $151,511	-1,922 Reduced 2.65%	70,606 $5.3 Million
Q2 2021 Jul 15, 2021	SELL	$70.31 - $77.77 $966,832 - $1.07 Million	-13,751 Reduced 15.94%	72,528 $5.64 Million
Q1 2021 Apr 12, 2021	BUY	$68.86 - $81.11 $3.8 Million - $4.48 Million	55,245 Added 178.01%	86,279 $6.65 Million
Q4 2020 Jan 15, 2021	BUY	$71.77 - $79.65 $2.23 Million - $2.47 Million	31,034 New	31,034 $2.54 Million

3,821

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $244B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Founders Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Founders Capital Management, LLC with notifications on news.